Aspirin sensitivity in diabetes mellitus; the role of glycaemic control and dosing
- Conditions
- Diabetes mellitusCardiovascular disease
- Registration Number
- NL-OMON26330
- Lead Sponsor
- Prof. dr. J.B.L. HoekstraDept. of Internal MedicineAcademic Medical Centre
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 140
Inclusion Criteria
1. Age > 18 years
2. Diagnosis of type 2 diabetes
Exclusion Criteria
1. Current acetylsalicylic acid therapy
2. Use of any medication interfering with platelet function, e.g. diclofenac, naproxen or clopidogrel in the two weeks prior to the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method